Sinovac Schedules 2010 Annual Meeting of Shareholders

BEIJING, June 18 /PRNewswire-Asia/ — Sinovac
Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of
vaccines in China, announced today
that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be
held concurrently at No. 39 Shangdi Xi Road, Haidian District,
Beijing, PRC and at No. 6 Temple
Street, St. John’s, Antigua. All
shareholders of record as of May 26,
2010 will be eligible to vote and are invited to attend.
Sinovac 2009 annual report and the proxy statements are also be
available on the company’s website: http://www.sinovac.com/Investors/SECFilings/
http://www.sinovac.com/Investors/IRHome/presentation/.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company
that focuses on the research, development, manufacture and
commercialization of vaccines that protect against human infectious
diseases. Sinovac’s vaccine products include Healive(R) (hepatitis
A), Bilive(R) (combined hepatitis A and B), and Anflu(R)
(influenza). Panflu(TM), Sinovac’s pandemic influenza vaccine
(H5N1), h

‘/>”/>

SOURCE